Concepedia

Michelle Rowicki

MR

Statistics

Publications

4

Citations

419

H-Index

4

Active since

2019

Affiliations

Princeton University(Current)

Fudan University Shanghai Cancer Center

Rutgers Cancer Institute

Rutgers, The State University of New Jersey

University Medical Center of Princeton

Michelle Rowicki is an author at Princeton University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2019–2021

4

Publications

4

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling

Minhong Shen, Yi-Zhou Jiang, Yong Wei et al. · Cancer Cell · 2019 · 212 citations · Full text

, , +16

Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer

Minhong Shen, Heath A. Smith, Yong Wei et al. · Nature Cancer · 2021 · 78 citations · Full text

, , +16

Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis

Minhong Shen, Yong Wei, Hahn Kim et al. · Nature Cancer · 2021 · 77 citations · Full text

, , +12

Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis

Minhong Shen, Shanshan Xie, Michelle Rowicki et al. · Cancer Research · 2020 · 52 citations · Full text

, , +13

1–4 of 4